Whistler Conference Centre Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Diabetes: Innovations, Outcomes and Personalized Therapies (X3)

joint with the meeting on Unraveling the Secrets of Kidney Disease (X4)

Scientific Organizers: Philip J. Larsen, Melina Claussnitzer and Tina Vilsbøll


March 3—7, 2019

Whistler Conference Centre, Whistler, British Columbia, Canada


Supported by the Directors' Fund


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Nov 6, 2018 [details]
Discounted Abstract Deadline: Nov 6, 2018 [details]
Abstract Deadline: Dec 4, 2018 [details]
Discounted Registration Deadline: Jan 11, 2019 [details]

Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2019-X3 "Diabetes: Innovations, Outcomes and Personalized Therapies" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On November 6, 2018 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After November 6, 2018 until December 4, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
November 6, 2018 n/a
Discounted NON-STUDENT Registration
More details
Before and On January 11, 2019 945.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After January 11, 2019 1145.00 USD
Discounted STUDENT Registration
More details
Before and On January 11, 2019 720.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After January 11, 2019 920.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.

Apply for a Scholarship



Discounted Abstract Deadline: November 6, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is December 4, 2018)

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: November 6, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: December 4, 2018

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is November 6, 2018)

Discounted Registration Deadline: January 11, 2019

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 945.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1145.00 USD*
Student Registration Fee: 920.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, March 3 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 7 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 8 in order to fully experience the meeting.

SUNDAY, MARCH 3

16:00—20:00
Arrival and Registration

18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


MONDAY, MARCH 4

07:00—08:00
Breakfast

08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 02/03/2019

Harold I. Feldman†, University of Pennsylvania School of Medicine, USA
Genetic and Environmental Factors Controlling the Development and Progression of Kidney Disease; Lessons Learnt from the CRIC (Chronic Renal Insufficiency Cohort) Study

08:00—10:15
State of the Union for Diabetes Care anno 2019: What Should We Expect from a Stellar Novel Diabetes Drug?
Registered attendees can view abstracts starting on 02/03/2019

Peter Stein†, U.S. Food and Drug Administration, USA
End Point Expectations for Novel Diabetes Drugs: Is Glucocentric HbA1c Focus still the Right Treatment Goal or should we rather Pay Attention to other End Points?

Bernard Zinman, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Canada
Learnings from Empa-Reg Outcome and LEADER

Coffee Break

Tina Vilsbøll, Steno Diabetes Center Copenhagen, Denmark
How to Demonstrate Medical Value for Diabetes Drugs Fast and Convincingly

Short Talk(s) Chosen from Abstracts

09:00—11:15
Podocyte Diseases
Registered attendees can view abstracts starting on 02/03/2019

Friedhelm Hildebrandt, Howard Hughes Medical Institute and Boston Children’s Hospital, Harvard Medical School, USA
Monogenic causes of Podocyte Loss Reveal Targets for Personalized Treatment

Coffee Break

John Cijiang He, Icahn School of Medicine at Mount Sinai, USA
Mechanism of Podocyte Dysfunction

Stuart J. Shankland, University of Washington, USA
Understanding Podocyte Regeneration

Short Talk(s) Chosen from Abstracts

10:15—11:15
Keynote Address
Registered attendees can view abstracts starting on 02/03/2019

Leif C. Groop, Lund University, Sweden
Diabetes Comes in Different Flavors: On the Heterogeneity of Diabetes - Time for Reclassification of a Disease

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Workshop and Panel Discussion
Has industry lost appetite for investing in R&D aiming at improving diabetes care, and if yes, what would it take to reignite the interest?

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Diabetes and Its Many Phenotypes
Registered attendees can view abstracts starting on 02/03/2019

Michael P. Snyder, Stanford University School of Medicine, USA
Power of Personalized Genomic Medicine: How to Improve Diabetes Care

Tai E. Shyong, National University of Singapore, Singapore
Ethnically Determined Diabetes Variants (Asian Diabetes)

Juleen R. Zierath, Karolinska Institutet, Sweden
The Role of Diet and Exercise in Modifying the Epigenetic Landscape in Type 2 Diabetes

Short Talk Chosen from Abstracts

17:00—19:00
Immune Injury
Registered attendees can view abstracts starting on 02/03/2019

Ali Gharavi, Columbia University Medical Center, USA
Genetics of IgA Nephropathy/Role of Complement

Martin Pollak, Beth Israel Deaconess Medical Center, USA
Inflammation and APOL1-associated Kidney Disease

David J. Salant, Boston University School of Medicine, USA
PLA2R and Membranous Nephropathy

Matthias Kretzler, University of Michigan, USA
Progression Pathways in CKD

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


TUESDAY, MARCH 5

07:00—08:00
Breakfast

08:00—09:00
Keynote Address (Joint)
Registered attendees can view abstracts starting on 02/03/2019

Mark I. McCarthy, University of Oxford, UK
Can We Actually Learn Anything about Diabetes Risk from GWAS? Population-based Genetics

09:00—11:15
Genetics and Epigenetics of Diabetes and Complications (Joint)
Registered attendees can view abstracts starting on 02/03/2019

Anna Köttgen, University Freiburg Medical Center, Germany
Genetics of Kidney disease and Metabolite Traits

Coffee Break

Melina Claussnitzer, Harvard Medical School, Beth Israel Deaconess Medical Center, USA
Type 2 Diabetes and its Comorbidities: The Journey from GWAS to Disease Mechanism

Katalin Susztak, University of Pennsylvania, USA
Finding the G(ene) in GWAS for Kidney Disease

Short Talk(s) Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

16:30—17:00
Coffee Available

17:00—19:00
Deciphering Cellular Function of Target Tissues of Relevance for Diabetes
Registered attendees can view abstracts starting on 02/03/2019

Marcelo Nobrega, University of Chicago, USA
Experimental Dissection of the Cellular and Organismal Effects of T2D Genes

Pedro Herrera†, University of Geneva, Switzerland
The Making of a beta-Cell: Can Transdifferentiation of alpha Cells Help Normalizing Islet Function in Diabetes?

Chad A. Cowan, Harvard University, USA
Investigating Metabolic Disease with Human Pluripotent Stem Cells

Short Talk Chosen from Abstracts

17:00—19:00
Tubule Injury and Regeneration
Registered attendees can view abstracts starting on 02/03/2019

Benjamin D. Humphreys, Washington University School of Medicine, USA
Mapping Cell States to Understand Human Diabetic Nephropathy and Chronic Kidney Disease using Single Cell and Single Nucleus RNA-Seq

Masaomi Nangaku, University of Tokyo School of Medicine, Japan
The Role of Hypoxia and HIF in Tubule Injury

Mark Douglas Okusa, University of Virginia, USA
Immune Injury in AKI

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 2


WEDNESDAY, MARCH 6

07:00—08:00
Breakfast

08:00—11:00
Complications of Diabetes (Joint)
Registered attendees can view abstracts starting on 02/03/2019

Susan Quaggin, Northwestern University, USA
The Role of Endothelial Cell Injury in Diabetic Kidney Disease

Matthew D. Breyer, Eli Lilly and Company, USA
Therapeutic Targeting of the Endothelium in Diabetes

Coffee Break

Donald Kohan†, University of Utah, USA
Endothelin Receptor Antagonists in DKD: SONAR Study

Farhad Danesh, University of Texas MD Anderson Cancer Center, USA
Podocyte and Mitochondrial Dysfunction in Diabetes

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

16:30—17:00
Coffee Available

17:00—19:00
Omics Stuff and Profiling
Registered attendees can view abstracts starting on 02/03/2019

Christopher B. Newgard, Duke University Medical Center, USA
Biochemical Phenotyping of Metabolic Syndrome

Cecilia Lindgren, Oxford University, UK
Identifying Metabolic Cross-Trait Signatures Using UK Biobank

Hans-Ulrich Häring, Eberhard-Karls University Tübingen, Germany
Insulin Sensitization: Improving more than Glycemic Control

Short Talk Chosen from Abstracts

17:00—19:00
Endothelial Dysfunction in CKD
Registered attendees can view abstracts starting on 02/03/2019

Ananth Karumanchi†, Beth Israel Deaconess Medical Center, USA
VEGF and Angiogenic Factors in Preeclampsia and CKD

Janos Peti-Peterdi, University of Southern California, USA
The Physiological and Pathophysiological Regulation of Glomerular Blood Flow

Hiddo Lambers Heerspink, University Medical Center Groningen, Netherlands
SGLT2 Inhibitors and Diabetic Nephropathy and non-Diabetic CKD

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 3


THURSDAY, MARCH 7

07:00—08:00
Breakfast

08:00—11:00
Epigenomics of T2D
Registered attendees can view abstracts starting on 02/03/2019

Speaker to be Announced

Mitchell A. Lazar, Perelman School of Medicine, University of Pennsylvania, USA
Epigenomic Regulation of Metabolism

Coffee Break

Maike Sander, University of California, San Diego, USA
Epigenetic Adaptation in the beta Cell

Evan D. Rosen, Beth Israel Deaconess Medical Center, Harvard University, USA
Epigenetic Variability in Insulin Resistant States

Short Talk(s) Chosen from Abstracts

08:00—11:00
Precision Medicine
Registered attendees can view abstracts starting on 02/03/2019

Jonathan Himmelfarb, University of Washington, USA
Kidney on Chip for Drug Development

Coffee Break

Eugene Park Rhee, Massachusetts General Hospital, USA
Metabolomics To Understand Kidney Function

Rahul Satija, New York Genome Center, USA
Single Cell Immune Sequencing in Lupus Nephritis

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:30—16:30
Workshop

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—18:45
Metabolic Surgery
Registered attendees can view abstracts starting on 02/03/2019

Geltrude Mingrone†, King's College London, UK
Metabolic Improvements after Bariatric By-Pass Surgery: Solely Ascribable to Caloric Deficit or Does an Elusive Factor Assist?

Lee M. Kaplan, Massachusetts General Hospital, USA
Variability of Response and Prediction of Outcome

Filip K. Knop, Gentofte Hospital, University of Copenhagen, Denmark
The Liver-alpha Cell Axis: A New Endocrine System with (Patho)Physiologic and Pharmacologic Implications

Philip J. Larsen, Sanofi, Germany
Can We Translate Bariatric Surgery into Equi-Efficacious Pharmacotherapy

17:00—18:45
Novel Approaches for Drug Discovery
Registered attendees can view abstracts starting on 02/03/2019

Alan R. Shuldiner, Regeneron Pharmaceuticals, Inc, USA
Drug Discovery 2.0, the Use of Human Knock-Out Project

Caroline Fox, Merck Research Labs, USA
Using Genetics to Drive Drug Discovery

Alex Bell, Ionis Pharmaceuticals, USA
RNA Therapeutics for Kidney Disease

Stephanie Cherqui, University of California, San Diego, USA
Stem Cell and Gene Therapy for Cystonosis

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/03/2019

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 02/03/2019

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.


FRIDAY, MARCH 8

 
Departure


*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676